These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10408968)

  • 1. T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes.
    Hill M; Moss P; Wordsworth P; Newsom-Davis J; Willcox N
    J Neuroimmunol; 1999 Jun; 97(1-2):146-53. PubMed ID: 10408968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myasthenia induced by D-penicillamine. Apropos of 2 case reports].
    Huaux JP; Delreux V
    Acta Neurol Belg; 1986; 86(5):297-303. PubMed ID: 3492852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones.
    De Magistris MT; Di Tommaso A; Domenighini M; Censini S; Tagliabue A; Oksenberg JR; Steinman L; Judd AK; O'Sullivan D; Rappuoli R
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2990-4. PubMed ID: 1313575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.
    Delamere JP; Jobson S; Mackintosh LP; Wells L; Walton KW
    Ann Rheum Dis; 1983 Oct; 42(5):500-4. PubMed ID: 6605118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?
    Andonopoulos AP; Terzis E; Tsibri E; Papasteriades CA; Papapetropoulos T
    Clin Rheumatol; 1994 Dec; 13(4):586-8. PubMed ID: 7697959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA DR1 with high D-penicillamine binding to monocytes in females.
    Watanabe H; Kelly H; Dawkins RL
    Microbiol Immunol; 1987; 31(1):83-8. PubMed ID: 3495717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells receptor beta-chain repertoires are nonrandomly selected in responses to HLA-DR1.
    Hand SL; Alter MD; Finn OJ
    Transplantation; 1996 Apr; 61(7):1084-94. PubMed ID: 8623190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis.
    Pierce JL; Zborowski KA; Kraig E; Infante AJ
    Int Immunol; 1994 May; 6(5):775-83. PubMed ID: 8080845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follow-up and immunologic findings in drug-induced myasthenia].
    Brüggemann W; Herath H; Ferbert A
    Med Klin (Munich); 1996 May; 91(5):268-71. PubMed ID: 8709903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penicillamine-induced ocular myasthenia gravis.
    O'Keefe M; Morley KD; Haining WM; Smith A
    Am J Ophthalmol; 1985 Jan; 99(1):66-7. PubMed ID: 3966521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
    Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
    J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
    Fawcett PR; McLachlan SM; Nicholson LV; Argov Z; Mastaglia FL
    Muscle Nerve; 1982 Apr; 5(4):328-34. PubMed ID: 7099199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
    Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
    J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.
    Tzartos SJ; Morel E; Efthimiadis A; Bustarret AF; D'Anglejan J; Drosos AA; Moutsopoulos HA
    Clin Exp Immunol; 1988 Oct; 74(1):80-6. PubMed ID: 2464451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
    J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenia gravis caused by D-penicillamine].
    Sanz Gallego PJ; Pérez Sánchez FC; López Vázquez A; Salgado Palacio D
    Aten Primaria; 1996 Mar; 17(5):364-5. PubMed ID: 8722166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.